We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPC icon
301
Marathon Petroleum
MPC
$92.4B
$1.38M 0.03%
36,321
-1,664
-4% -$61.1K
MKC icon
302
McCormick & Company Non-Voting
MKC
$13.7B
$1.34M 0.03%
25,166
-700
-3% -$34.2K
CNC icon
303
Centene
CNC
$30.7B
$1.34M 0.03%
37,484
+300
+0.8% +$9.42K
PID icon
304
Invesco International Dividend Achievers ETF
PID
$926M
$1.33M 0.03%
94,357
+7,355
+8% +$104K
TTM
305
DELISTED
Tata Motors Limited
TTM
$1.33M 0.03%
38,294
TJX icon
306
TJX Companies
TJX
$174B
$1.33M 0.03%
34,360
-3,200
-9% -$122K
SKX
307
DELISTED
Skechers
SKX
$1.32M 0.03%
44,585
+205
+0.5% +$6.19K
PSX icon
308
Phillips 66
PSX
$84.9B
$1.32M 0.03%
16,691
-747
-4% -$61K
M icon
309
Macy's
M
$6.53B
$1.32M 0.03%
39,279
-333,518
-89% -$11.9M
CEO
310
DELISTED
CNOOC Limited
CEO
$1.31M 0.03%
10,525
+4,655
+79% +$561K
RTX icon
311
RTX Corp
RTX
$290B
$1.3M 0.03%
20,117
+191
+1% +$12.2K
EFX icon
312
Equifax
EFX
$20.3B
$1.29M 0.03%
10,040
-400
-4% -$48.4K
COR icon
313
Cencora
COR
$60.6B
$1.28M 0.03%
16,150
CAT icon
314
Caterpillar
CAT
$375B
$1.27M 0.03%
16,815
-1,426
-8% -$107K
NVO
315
Novo Nordisk
NVO
$208B
$1.27M 0.03%
47,420
-4,220
-8% -$116K
WY icon
316
Weyerhaeuser
WY
$18B
$1.27M 0.03%
42,746
-999
-2% -$30.7K
CSX icon
317
CSX Corp
CSX
$93.4B
$1.27M 0.03%
145,974
+6
+0% +$52
SEM
318
DELISTED
Select Medical
SEM
$1.25M 0.03%
214,233
+1,263
+0.6% +$8.37K
BSCH
319
DELISTED
Guggenheim BulletShares 2017 Corporate Bond ETF
BSCH
$1.24M 0.03%
54,218
+42,498
+363% +$966K
KEP icon
320
Korea Electric Power
KEP
$15.3B
$1.23M 0.03%
47,530
+3,600
+8% +$92.9K
ELS icon
321
Equity Lifestyle Properties
ELS
$12.6B
$1.21M 0.03%
+30,340
New +$1.1M
MANH icon
322
Manhattan Associates
MANH
$11.2B
$1.21M 0.03%
18,897
+1,686
+10% +$105K
VOO icon
323
Vanguard S&P 500 ETF
VOO
$979B
$1.2M 0.03%
6,241
+388
+7% +$73.9K
EAT icon
324
Brinker International
EAT
$9.17B
$1.19M 0.03%
26,184
-455
-2% -$20.8K
BSCI
325
DELISTED
Invesco BulletShares 2018 Corporate Bond ETF
BSCI
$1.18M 0.03%
55,341
+41,984
+314% +$892K

Similar funds

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.